Results 231 to 240 of about 714,581 (348)

Exploring the use of telemedicine to expand addiction and recovery resources in Great Plains Tribal Communities. [PDF]

J Rural Health
Harding MC, Kihlstrom AC, Kelliher A, Rosa C, Kropp FB, Winhusen TJ, Warne DK.   +6 more
europepmc   +1 more source

Mental Health and the Constitution: How Incarcerating the Mentally Ill Might Pave the Way to Treatment

, 2020
Caspar, Samantha M., Joukov, Artem M.
core  

Serious Opioid Injection-Related Infection and Initiation of Medication for Opioid Use Disorder

JAMA Network Open
openaire   +2 more sources

Navigating pregnancy and addiction recovery: Patient perspectives on perinatal care interventions for women with opioid use disorder in Kentucky, USA

Addiction, EarlyView.
Abstract Background and aims The state of Kentucky has been heavily impacted by the ongoing opioid crisis in the United States, with high overdose mortality, high prevalence of opioid use disorder (OUD), elevated maternal mortality and incidence of Neonatal Abstinence Syndrome.
Hilary L. Surratt, Olivia A. Davis, Elizabeth O. Nelson, Hayley Durr, Karen Fawcett, Jason Joy, Brandon L. Schanbacher, Marie Vice, John A. Bauer, Wendy F. Hansen   +9 more
wiley   +1 more source

Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences. [PDF]

Int J Environ Res Public Health
Pallucchini A, Varese M, Pergentini I, Gemignani S, Parapetto E, Maremmani I, Maremmani AGI.   +6 more
europepmc   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, EarlyView.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Ibogaine: Therapeutic Potential, Cardiac Safety, and Translational Perspectives in the Treatment of Substance Use Disorders-A Scoping Review. [PDF]

Molecules
Esperança MP, Gomes NGM, Campos MG.
europepmc   +1 more source

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

Addiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu, Chia‐Chun Hung, Marc N. Potenza, Kun‐Hsien Chou, Pei‐Lin Lee, Chu‐Chung Huang, Chiang‐Shan R. Li, Tony Szu‐Hsien Lee, Ching‐Po Lin   +8 more
wiley   +1 more source

Biosurveillance and the Opioid Crisis in Emergency Medicine: Qualitative Study of Physician Perspectives. [PDF]

JMIR Form Res
Stilley JAW, Benton M, Douglas AE, Kapp JM.   +3 more
europepmc   +1 more source

Predictors of outpatient treatment engagement following a visit to a specialized emergency department for substance use: A cohort study using high‐resolution electronic health records

Addiction, EarlyView.
Abstract Background and aims Substance‐related emergency department (ED) visits represent a critical opportunity to link individuals with sustained treatment for substance use disorders (SUD), yet few transition to post‐acute treatment. Among emerging initiatives to integrate specialized SUD care into ED services, the Stockholm SUD‐ED is an example of ...
Danilo Romero, Martin Kåberg, Anne H. Berman, Per Carlbring, Johan Franck, Philip Lindner   +5 more
wiley   +1 more source